- New research shows many college students use CBD to cope.
- Many students try it for anxiety and worry.
- Some students use it to sleep better at night.
- Other students use it to feel less stress.
- Friends often offer or share CBD products in groups.
- Edible forms, such as gummies, are very common.
- Some students try CBD more than once.
- Researchers say more study is needed on CBD.
- CBD does not make people feel high.
- Rules about CBD vary by place.
Difficult words
- research — careful study to find new information
- cope — manage or deal with a hard situation
- anxiety — strong worry or nervous feeling
- stress — feeling of pressure or worry
- edible — food you can eat, not smoke
- gummies — small sweet candies you can eat
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever tried CBD?
- Do you sometimes feel stress or anxiety?
- Do your friends offer or share things with you?
Related articles
Gagandeep Kang on Vaccines, Surveillance and Child Health in India
Gagandeep Kang, a leading expert on enteric diseases, urges India to prepare tools to prevent viral outbreaks. She helped develop indigenous rotavirus vaccines, built surveillance networks and now works at the Gates Foundation.
Africa uses AI to strengthen health systems and self-reliance
At the CPHIA conference in Durban, Africa CDC said AI and digital tools can help protect 1.4 billion people, improve surveillance and support primary health care. Data governance, infrastructure and domestic financing are key concerns.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
Gene Variant Raises Heart Failure Risk After Myocarditis in Children
A study found that a cardiomyopathy gene variant is more common in children who develop dilated cardiomyopathy after myocarditis. Researchers describe a "double hit" model and advise genetic testing to identify higher risk.
